ES2063013T3 - Procedimiento para eliminar pirogenos. - Google Patents

Procedimiento para eliminar pirogenos.

Info

Publication number
ES2063013T3
ES2063013T3 ES88117146T ES88117146T ES2063013T3 ES 2063013 T3 ES2063013 T3 ES 2063013T3 ES 88117146 T ES88117146 T ES 88117146T ES 88117146 T ES88117146 T ES 88117146T ES 2063013 T3 ES2063013 T3 ES 2063013T3
Authority
ES
Spain
Prior art keywords
pyrogens
eliminating
procedure
solution
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88117146T
Other languages
English (en)
Inventor
Tadashi Sato
Taizo Watanabe
Satoshi Minobe
Takashi Nishimura
Masahiro Kagotani
Tomonobu Ase
Zenjiro Honda
Shinji Nagamatsu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daicel Corp
Tanabe Pharma Corp
Original Assignee
Tanabe Seiyaku Co Ltd
Daicel Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co Ltd, Daicel Chemical Industries Ltd filed Critical Tanabe Seiyaku Co Ltd
Application granted granted Critical
Publication of ES2063013T3 publication Critical patent/ES2063013T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/14—Ultrafiltration; Microfiltration
    • B01D61/145—Ultrafiltration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A61L2/022—Filtration
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • C—CHEMISTRY; METALLURGY
    • C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F1/00—Treatment of water, waste water, or sewage
    • C02F1/44—Treatment of water, waste water, or sewage by dialysis, osmosis or reverse osmosis
    • C02F1/444—Treatment of water, waste water, or sewage by dialysis, osmosis or reverse osmosis by ultrafiltration or microfiltration

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Water Supply & Treatment (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Environmental & Geological Engineering (AREA)
  • Hydrology & Water Resources (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Medicinal Preparation (AREA)
  • Water Treatment By Sorption (AREA)

Abstract

LOS PIROGENOS SE ELIMINAN DE UNA DISOLUCION DE LOS MISMOS (1) TRATANDO LA DISOLUCION CON UNA MEMBRANA Y LUEGO (2) TRATANDO LA DISOLUCION RESULTANTE CON UN ABSORBENTE DE PIROGENOS. LA DISOLUCION OBTENIDA ES UTIL EN EL CAMPO FARMACEUTICO.
ES88117146T 1987-10-16 1988-10-14 Procedimiento para eliminar pirogenos. Expired - Lifetime ES2063013T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP26137087 1987-10-16
JP63221877A JPH0829316B2 (ja) 1987-10-16 1988-09-05 パイロジェンの除去方法

Publications (1)

Publication Number Publication Date
ES2063013T3 true ES2063013T3 (es) 1995-01-01

Family

ID=26524551

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88117146T Expired - Lifetime ES2063013T3 (es) 1987-10-16 1988-10-14 Procedimiento para eliminar pirogenos.

Country Status (7)

Country Link
US (1) US4909942A (es)
EP (1) EP0312104B1 (es)
JP (1) JPH0829316B2 (es)
KR (1) KR910004581B1 (es)
CA (1) CA1330049C (es)
DE (1) DE3887812T2 (es)
ES (1) ES2063013T3 (es)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5589591A (en) * 1986-07-03 1996-12-31 Advanced Magnetics, Inc. Endotoxin-free polysaccharides
US5032281A (en) * 1989-08-09 1991-07-16 Daicel Chemical Industries, Ltd. Separating membrane and separation method
US5136032A (en) * 1989-12-07 1992-08-04 Daicel Chemical Industries, Ltd. Method for separating phosphopolyol compounds using a separating agent
US5104546A (en) * 1990-07-03 1992-04-14 Aluminum Company Of America Pyrogens separations by ceramic ultrafiltration
DE4029088C1 (es) * 1990-09-13 1992-02-13 Fresenius Ag, 6380 Bad Homburg, De
US5242595A (en) * 1991-04-25 1993-09-07 U.S. Filter/Illinois Water Treatment, Inc. Bacteria removal by ceramic microfiltration
US5731164A (en) * 1991-08-06 1998-03-24 Sanorell Pharma Gmbh & Co. method of checking the rate of removal of pyrogenic substances, in particular viruses, from organic material
EP0549239B1 (en) * 1991-12-24 1997-08-06 Wako Pure Chemical Industries Ltd Process for extracting endotoxin
AUPN030794A0 (en) 1994-12-22 1995-01-27 Aruba International Pty Ltd Discontinuous plasma or serum delipidation
IT1275427B (it) * 1995-05-16 1997-08-07 Bracco Spa Processo per la depirogenazione di soluzioni farmaceutiche iniettabili
IT1279209B1 (it) * 1995-05-16 1997-12-04 Bellco Spa Filtro dializzatore/reattore atto ad effettuare la cattura di endotossine, e procedimento per la sua realizzazione.
DE19609479A1 (de) * 1996-03-11 1997-09-18 Biotechnolog Forschung Gmbh Endotoxin-spezifische Membranen
DE19736472C1 (de) * 1997-08-21 1999-04-22 Bernhard Dr Sixt Verfahren zum Herstellen von weitgehend nebenwirkungsfreien Kontrastmitteln
WO2000072014A1 (en) * 1999-05-25 2000-11-30 Board Of Regents Of University Of Nebraska Method of detecting and quantifying endotoxins
US6585890B2 (en) 2000-02-04 2003-07-01 Applied Research Associates, Inc. Process for producing sterile water for injection from potable water
US6716970B2 (en) * 2000-04-21 2004-04-06 Adjuvant Pharmaceuticals, Llc Water soluble, randomly substituted partial N-partial O-acetylated chitosan, preserving compositions containing chitosan, and processes for making thereof
EP1289629B1 (en) * 2000-05-18 2004-08-04 Novozymes A/S Microfiltration using activated carbon
US7439052B2 (en) * 2000-06-29 2008-10-21 Lipid Sciences Method of making modified immunodeficiency virus particles
US20090017069A1 (en) * 2000-06-29 2009-01-15 Lipid Sciences, Inc. SARS Vaccine Compositions and Methods of Making and Using Them
US7407663B2 (en) 2000-06-29 2008-08-05 Lipid Sciences, Inc. Modified immunodeficiency virus particles
US7407662B2 (en) 2000-06-29 2008-08-05 Lipid Sciences, Inc. Modified viral particles with immunogenic properties and reduced lipid content
AUPQ846900A0 (en) * 2000-06-29 2000-07-27 Aruba International Pty Ltd A vaccine
EP1412045A4 (en) * 2001-06-25 2007-05-02 Lipid Sciences Inc A SOLVENT FOR REMOVING LIPIDES FROM FLUIDS USING SYSTEMS AND METHOD
US20060060520A1 (en) * 2001-06-25 2006-03-23 Bomberger David C Systems and methods using a solvent for the removal of lipids from fluids
US6991727B2 (en) * 2001-06-25 2006-01-31 Lipid Sciences, Inc. Hollow fiber contactor systems for removal of lipids from fluids
US20030127386A1 (en) * 2001-06-25 2003-07-10 Bomberger David C. Hollow fiber contactor systems for removal of lipids from fluids
WO2003000381A1 (en) * 2001-06-25 2003-01-03 Lipid Sciences, Inc. Hollow fiber contactor systems for removal of lipids from fluids
US7122149B2 (en) * 2002-07-12 2006-10-17 Applied Research Associates, Inc. Apparatus and method for continuous depyrogenation and production of sterile water for injection
EP1534243A4 (en) * 2002-08-26 2008-08-13 Lipid Sciences Inc TREATMENT OF ALZHEIMER WITH ENTLIPIDED PROTEIN PARTICLES
DK1641421T3 (en) * 2003-07-03 2019-03-11 Hdl Therapeutics Inc Methods and apparatus for producing HDL particle derivatives of reduced lipid content
US7393826B2 (en) 2003-07-03 2008-07-01 Lipid Sciences, Inc. Methods and apparatus for creating particle derivatives of HDL with reduced lipid content
US7125967B2 (en) * 2003-10-08 2006-10-24 Adjuvant Pharmaceuticals, Llc Water-soluble chitosan having low endotoxin concentration and methods for making and using the same
US6960803B2 (en) * 2003-10-23 2005-11-01 Silicon Storage Technology, Inc. Landing pad for use as a contact to a conductive spacer
CN104190387B (zh) * 2014-09-11 2016-08-17 福州新北生化工业有限公司 一种除液体中热原的凝胶及其制备方法和应用
CN105251049B (zh) * 2015-09-29 2018-04-10 浙江星月生物科技股份有限公司 一种去除生物医用材料中细菌内毒素的离子缓冲液及应用
US11027052B2 (en) 2017-11-22 2021-06-08 HDL Therapuetics, Inc. Systems and methods for priming fluid circuits of a plasma processing system
EP3731814A4 (en) 2017-12-28 2021-09-29 HDL Therapeutics, Inc. METHOD OF PRESERVATION AND ADMINISTRATION OF HIGH DENSITY PRE-BETA LIPOPROTEIN EXTRACTED FROM HUMAN PLASMA
WO2021261143A1 (ja) * 2020-06-23 2021-12-30 オルガノ株式会社 過酸化水素の除去方法及び除去装置並びに純水製造装置

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4261834A (en) * 1978-05-18 1981-04-14 Millipore Corporation Device and process for removing pyrogens from aqueous solutions
US4276177A (en) * 1979-08-13 1981-06-30 Vaponics Inc. High efficiency filtration with impurity concentration and ultrafiltration rejection flow recirculation
US4412985A (en) * 1980-10-06 1983-11-01 Edward Shanbrom Depyrogenation process
EP0056855B1 (en) * 1980-12-02 1985-11-21 Tracor, Inc. Preparation of infusion grade water
GB2092470B (en) * 1981-02-10 1984-07-18 Tanabe Seiyaku Co Method for reducing the pyrogen content of or removing pyrogens from solutions contaminated therewith
AU540708B2 (en) * 1982-01-25 1984-11-29 Mitsubishi Rayon Company Limited Water purifying method and system
EP0110580A3 (en) * 1982-11-03 1986-06-11 Gelman Sciences, Inc. Improved process for removing pyrogens utilizing a hydrophobic microporous membrane
JPS6013215U (ja) * 1983-07-04 1985-01-29 株式会社クラレ 飲料水製造装置
US4610790A (en) * 1984-02-10 1986-09-09 Sterimatics Company Limited Partnership Process and system for producing sterile water and sterile aqueous solutions

Also Published As

Publication number Publication date
US4909942A (en) 1990-03-20
EP0312104A3 (en) 1989-08-09
DE3887812T2 (de) 1994-05-19
JPH01194991A (ja) 1989-08-04
JPH0829316B2 (ja) 1996-03-27
EP0312104B1 (en) 1994-02-16
KR910004581B1 (ko) 1991-07-06
EP0312104A2 (en) 1989-04-19
DE3887812D1 (de) 1994-03-24
CA1330049C (en) 1994-06-07
KR890006221A (ko) 1989-06-12

Similar Documents

Publication Publication Date Title
ES2063013T3 (es) Procedimiento para eliminar pirogenos.
ES2075202T3 (es) Nuevas arilpiridazinas, su preparacion, su utilizacion, y medicamentos que las contienen.
IT1209603B (it) Derivati 2,6-disostituiti di naftalene, procedimento per prepararli e loro uso nel campo farmaceutico e cosmetico.
ES2171158T3 (es) Derivados de oxatiolano cristalizados.
ES2161291T3 (es) N-(indol-2-carbonil)amidas y derivados como inhibidores de la glucogeno fosforilasa.
ES2139574T3 (es) Nuevos gases propulsores y su uso en preparaciones medicas.
ES2059729T5 (es) Preparado farmaceutico de liberacion controlada y metodo para producir el mismo.
DK0509019T3 (da) Behandling af humane retrovirale infektioner med 2',3'-dideoxyinosin
ES2075050T3 (es) Peptidos que tienen actividad cooperadora de celulas t.
AR003938A1 (es) Compuestos triciclicos de urea utiles para la inhibicion de la funcion de la proteina g y para tratamiento de enfermedades proteoliticas, composicionfarmaceutica, y el uso de los mismos para la preparacion de medicamentos.
ES2060399T3 (es) Cristales de la hormona del crecimiento y procedimiento para la produccion de estos cristales de la hormona del crecimiento.
ES2186714T3 (es) Uso de sustipo simple alpha 8 en la preparacion de medicamentos para el tratamiento de infecciones virales del higado.
IS3284A7 (is) Aðferð við framleiðslu á N1-súbstitúeruðum bensimidasólafleiðum til að nota við lækningar
ES2051678T1 (es) Derivados de 5-oxo-l-prolina y uso farmaceutico de los mismos.
ES2089687T3 (es) 4-fenil-piridonas y 4-fenil-2-alcoxipiridinas sustituidas como inhibidores de la hmg-coa-reductasa.
ES2101230T3 (es) Nuevos derivados de sustancias anti-inflamatorias, analgesicas y/o antipireticas no estereoideas, su uso y formulaciones farmaceuticas que las contienen.
IE900098L (en) The use of the active substance azelastine in combatting¹psoriasis disorders and inflammatory disorders
ES2193233T3 (es) Uso de amiodipina, una sal de la misma o felodipina en combinacion con un inhibidor ace en la fabricacion de un medicamento para el tratamiento de insuficiencia cardiaca conjuntiva no isquemica.
ECSP941120A (es) Derivados de 1,5 benzodiazepina
ES2038969T3 (es) Procedimiento para la renaturalizacion de proteinas.
DE3582594D1 (de) Proglumid und dessen pharmazeutische zusammensetzungen zur anwendung bei der behandlung von neoplastischen affektionen.
MX9704034A (es) Derivados y composiciones de 1,1-dioxido de 2-arilcarboniloximetil-1,2,5-tiadiazolidin-3-ona substituido y metodo de uso.
MX9301235A (es) DERIVADOS 1,4-DIOXINO(2,3-B)PIRIDINA. á
ES2145234T3 (es) Derivados de la diosmetina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2122962T3 (es) Derivados de alquileno-dioxibenceno opticamente activos y su uso en terapia.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 312104

Country of ref document: ES